Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to cyclopentano-hydrophenanthrene ; derivative thereof
Patent
1993-06-03
1996-08-27
Wu, Shean
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to cyclopentano-hydrophenanthrene ; derivative thereof
424153, 424 169, 424 9341, 530333, 530337, 530300, A61K 5108, A61K 4900, C07K 100, C07K 200
Patent
active
055498833
ABSTRACT:
A chemically defined polymeric carrier comprising a series of .alpha.-amino acids in any combination containing side chains to which diagnostic/therapeutic and chelating agents can be covalently joined through cleavable linkers either directly or covalently joined through cleavable linkers after chemical modification of the side chains. Hydrazone, disulfide, and ester linkages in any combination can be present in the polymeric carrier between the side chains of the .alpha.-amino acids and the agents. The presence of a particular covalent linkage between the side chain and the agent in the carrier is determined by the functional group present in the side chain of the .alpha.-amino acid and the functional group present in the agent. The .alpha.-amino acids with side chains to which agents do not covalently join can function as spacers to minimize interaction between bulky molecules attached to the polymeric carrier. In addition, those .alpha.-amino acids with charged or hydrophilic side chains to which agents do not covalently join can provide increased solubility to the polymeric carrier.
REFERENCES:
patent: 4485093 (1984-11-01), Runge et al.
patent: 4543211 (1985-09-01), Kato et al.
patent: 4587046 (1986-05-01), Goodman et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4867973 (1989-09-01), Goers et al.
patent: 4906452 (1990-03-01), Sivam
patent: 4950469 (1990-08-01), Katz
patent: 4952394 (1990-08-01), Senter
patent: 4997913 (1991-03-01), Hellstrom et al.
patent: 5087616 (1992-02-01), Myers et al.
patent: 5094848 (1992-03-01), Brixner
patent: 5162505 (1992-11-01), Dean et al.
patent: 5364613 (1994-11-01), Sieving et al.
Torchlin et al., Hybridoma, vol. 6: pp. 229-240 (1987).
Ghose et al., Methods in Enzymology, vol. 93: pp. 280-333 (1983).
Haseman et al., J. Nuclear Med., vol. 12: pp. 455-460 (1986).
Meares et al., Int. J. Cancer (Suppl. United States) vol. 2: pp. 99-102 (1988).
Deshpande et al., Int. J. Rad. Appl. Instrum. (B) Eng. vol. 16, No. 6; pp. 587-597 (1989).
R. V. Peterson, Chemical Abstract, vol. 94, No. 18, May 1981, Columbus, Ohio, Abstract No. 145233d, "Controlled release of progestins from poly(alpha-amino acid) carriers." p. 364.
J. C. Craig et al, Chemical Abstract, vol. 91, No. 12, Sep. 1979, Columbus, Ohio, Abstract No. 96584w, "Biological activity of isoproterenol covalently linked to synthetic polypeptides." p. 232.
W. A. R. Van Heeswijk et al, Journal of Controlled Release, vol. 1, No. 4, Jun. 1985, Amsterdam, Netherlands, "The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. part 1. " pp. 301-315.
Brixner Diana I.
Srinivasan Ananthachari
Vrudhula Vivekananda M.
Chapman Lara E.
NeoRx Corporation
Wu Shean
LandOfFree
Chemically defined polymeric carriers for release of covalently does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemically defined polymeric carriers for release of covalently , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemically defined polymeric carriers for release of covalently will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1054764